ANAVEX LIFE SCIENCES CORP. Debt Related Commitment Fees and Debt Issuance Costs
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Debt Related Commitment Fees and Debt Issuance Costs of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DebtRelatedCommitmentFeesAndDebtIssuanceCosts · last filed 2020-12-28
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for the quarter ending 2018-09-30 was $0.00.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for the quarter ending 2018-06-30 was $30.94K.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for the quarter ending 2016-09-30 was $4.64K, a 99.67% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for the quarter ending 2016-06-30 was $8.00, a 100.00% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for fiscal 2019 was $151.13K, a 388.42% increase from fiscal 2018.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for fiscal 2018 was $30.94K.
- ANAVEX LIFE SCIENCES CORP. debt related commitment fees and debt issuance costs for fiscal 2016 was $5.81K, a 99.88% decline from fiscal 2015.
| Period end | Debt Related Commitment Fees and Debt Issuance Costs 3 month | Debt Related Commitment Fees and Debt Issuance Costs 6 month | Debt Related Commitment Fees and Debt Issuance Costs 9 month | Debt Related Commitment Fees and Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-12-28 | |||
| 2019-09-30 | $151.13K 10-K · filed 2020-12-28 | |||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | $30.94K derived: sum of 2 quarters · filed 2019-12-16 | $30.94K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $30.94K 10-Q · filed 2019-08-07 | $30.94K 10-Q · filed 2019-08-07 | ||
| 2016-09-30 | $4.64K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-25 | $4.64K derived: sum of 2 quarters · filed 2019-01-25 | $4.72K derived: sum of 3 quarters · filed 2019-01-25 | $5.81K 10-K · filed 2019-01-25 |
| 2016-06-30 | $8.00 10-Q · filed 2017-08-07 | $80.00 derived: sum of 2 quarters · filed 2017-08-07 | $1.18K 10-Q · filed 2017-08-07 | $1.41M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $72.00 10-Q · filed 2017-05-10 | $1.17K 10-Q · filed 2017-05-10 | $1.41M derived: sum of 3 quarters · filed 2017-12-11 | $4.12M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $1.09K 10-Q · filed 2017-02-07 | $1.41M derived: sum of 2 quarters · filed 2017-12-11 | $4.12M derived: sum of 3 quarters · filed 2017-12-11 | $5.04M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $4.12M derived: sum of 2 quarters · filed 2017-12-11 | $5.04M derived: sum of 3 quarters · filed 2017-12-11 | $5.00M 10-K · filed 2017-12-11 |
| 2015-06-30 | $2.72M 10-Q · filed 2016-08-11 | $3.63M derived: sum of 2 quarters · filed 2016-08-11 | $3.59M 10-Q · filed 2016-08-11 | |
| 2015-03-31 | $912.36K 10-Q · filed 2016-05-11 | $874.71K 10-Q · filed 2016-05-11 | ||
| 2014-12-31 | -$37.65K 10-Q · filed 2016-02-08 | |||
| 2014-09-30 | $8.62M 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |